I’m looking for education in
Clinical Topic
Webcast
1.50 AMA PRA
From Delay to Damage
Webcast
1.00 AMA PRA
Finding the Path in Idiopathic Hypersomnia:
Webcast
1.25 CME/CE
Shining a Light
1.25
AMA PRA
HIV Prevention Strength Training
Webcast
1.50 CME
On Track for Change
Webcast
1.00 CME
Workshop 1: Penn State Neurscience Institute
Webcast
1.00 CME
Finding the Path in Nonadvanced Systemic Mastocytosis
Webcast Series
0.75
CME/CE
Team at the Center
Webcast
1.50 AMA PRA
From Delay to Damage
Changing the EGPA Trajectory With Early Diagnosis and Biologic Therapy
| Faculty: | Brian D. Jaros, MD; Philip Seo, MD, MHS; Michael E. Wechsler, MD, MMSc |
| Release: | 10/29/2025 |
| Expiration: | 11/29/2025 |
Webcast
1.00 AMA PRA
Finding the Path in Idiopathic Hypersomnia:
Best Practices in Diagnosis and Management
| Faculty: | Anne Marie Morse, DO, FAASM; Haley Wall |
| Release: | 10/29/2025 |
| Expiration: | 10/29/2026 |
Webcast
1.25 CME/CE
Shining a Light
on the PCP’s Role in HIV Prevention
| Faculty: | Shauna Applin, A-NP, AAHIVs |
| Release: | 10/27/2025 |
| Expiration: | 10/27/2026 |
Webcast
1.50 CME
On Track for Change
Are You on Pace With the Evolving Treatment Landscape in SCD?
| Faculty: | Modupe Idowu, MD; Santosh L. Saraf, MD; India Sisler, MD |
| Release: | 10/17/2025 |
| Expiration: | 11/14/2025 |
Webcast
1.00 CME
Workshop 1: Penn State Neurscience Institute
On-Demand: Laying the Foundation for Administering Antiamyloid mAbs for Patients With Early AD
| Faculty: | David C. Weisman, MD |
| Release: | 10/10/2025 |
| Expiration: | 11/07/2025 |
Webcast
1.00 CME
Finding the Path in Nonadvanced Systemic Mastocytosis
Best Practices in Recognition and Management
| Faculty: | John M. Fahrenholz, MD |
| Release: | 10/03/2025 |
| Expiration: | 10/03/2026 |
Webcast Series
0.75 CME/CE
Team at the Center
| Course 1: | Management of newly diagnosed patient with intermediate-stage HCC |
| Course 2: | Management of patients with intermediate-stage HCC who progressed after a partial response to TACE therapy |
| Course 3: | Management of a patient with intermediate-stage HCC who has experienced a TRAE |
